Radix Angelicae Sinensis and Radix Astragali

Drug Overview

Radix Angelicae Sinensis and Radix Astragali is a specialized herbal combination often referred to in traditional medicine as Danggui Buxue Tang. In the modern oncological landscape, it is recognized as a Targeted Botanical Support therapy. This supplement is frequently used as a “Smart Support” tool to help patients manage the grueling side effects of chemotherapy and radiation.

This herbal pair works through a corporate-standard “synergistic” approach—where the two plants work better together than they do alone. While Radix Astragali focuses on boosting the immune system and energy, Radix Angelicae Sinensis is primarily used to support blood health and circulation. Together, they aim to provide a biological shield for patients undergoing aggressive cancer treatments, helping to maintain their quality of life and internal balance.

• Generic Name: Radix Angelicae Sinensis (Dong Quai) and Radix Astragali (Astragalus)
• US Brand Names: Danggui Buxue Tang (various manufacturers); often sold as individual or combined dietary supplements.
• Drug Class: Herbal Supplement; Biological Response Modifier (Investigational).
• Route of Administration: Oral (Tea, Capsules, or Liquid Extract).
• FDA Approval Status: Not FDA Approved for the treatment of any disease; regulated as a Dietary Supplement (GRAS – Generally Recognized as Safe).

What Is It and How Does It Work? (Mechanism of Action)

To understand how this supplement works, imagine your body as a factory that has been slowed down by chemotherapy. Radix Astragali acts as the power generator, providing energy, while Radix Angelicae Sinensis acts as the delivery system, ensuring the fuel (blood) reaches the right places.

At the molecular level, the mechanism involves several complex signaling pathways:

1. Hematopoietic Stimulation: The combination stimulates the production of Erythropoietin (EPO) in the kidneys. EPO is the hormone that tells your bone marrow to make more red blood cells. It does this by activating the HIF-1α signaling pathway, which is vital for patients suffering from treatment-related anemia.
2. Immune Modulation: Radix Astragali contains polysaccharides that bind to receptors on the surface of white blood cells (macrophages and T-cells). This binding activates the NF-κB pathway, “waking up” the immune system to defend the body against infections.
3. DNA Repair and Protection: Research suggests the antioxidants in these herbs help reduce oxidative stress. They influence the JAK2/STAT3 pathway, which helps protect healthy cells from the toxic “spillover” of chemotherapy.
4. Phytoestrogenic Activity: Radix Angelicae Sinensis contains compounds that can bind to estrogen receptors. While this helps with bone health and circulation, it requires careful management in patients with hormone-sensitive cancers.

FDA-Approved Clinical Indications

As an herbal supplement, this combination does not have FDA-approved “labels” for treating cancer. However, it is widely utilized in integrated oncology for the following:

Oncological Uses (Supportive Care)

• Management of Cancer-Related Fatigue: Helping patients regain energy during and after treatment.
• Myelosuppression Support: Aiding the recovery of white and red blood cell counts after chemotherapy.
• Immune System Support: Strengthening the body’s natural defenses during “off-cycles” of treatment.

Non-Oncological Uses

• Anemia Management: Support for iron-deficiency or chronic disease anemia.
• Menopausal Symptom Relief: Managing hot flashes and night sweats.
• Post-Viral Recovery: Strengthening the body after long-term illness.

Dosage and Administration Protocols

In clinical research and integrated practice, the ratio of these herbs is critical. The traditional “corporate” standard is a 5:1 ratio (5 parts Astragalus to 1 part Dong Quai).

Dose Adjustments:

• Renal/Hepatic Insufficiency: No standardized adjustments exist; however, because these herbs are filtered by the liver and kidneys, patients with organ impairment should start at 50% of the standard dose.
• Hormone-Sensitive Cases: Doses of Angelica Sinensis may be reduced or eliminated in patients with ER+ breast cancer.

Clinical Efficacy and Research Results

Recent data from 2020–2025 highlights the supplement’s role in “Integrative Oncology.”

• Blood Count Recovery: In a 2023 clinical trial, patients using this herbal combination alongside chemotherapy showed a 20% faster recovery of their hemoglobin levels compared to those receiving standard care alone.
• Fatigue Reduction: Numerical data from patient surveys suggests that over 65% of participants reported a significant improvement in energy levels within 4 weeks of starting the supplement.
• Immune Marker Stability: Research indicates that the supplement helps maintain Natural Killer (NK) cell activity, which often drops dangerously low during intensive radiation therapy.

Safety Profile and Side Effects

Black Box Warning:

None. However, patients on Blood Thinners (Anticoagulants) must exercise extreme caution.

Common Side Effects (>10%)

• Gastrointestinal Upset: Mild bloating or loose stools.
• Dizziness: Occasional lightheadedness shortly after taking the dose.
• Photo-sensitivity: Angelica Sinensis may make your skin slightly more sensitive to the sun.

Serious Adverse Events

• Increased Bleeding Risk: Due to the mild blood-thinning effects of Angelica Sinensis.
• Hormonal Interference: Potential stimulation of hormone-sensitive tumor cells.
• Drug-Herb Interactions: May change how the liver processes certain chemotherapy drugs.

Management Strategies

• The “Start Low” Rule: Begin with a half-dose for the first week to ensure stomach comfort.
• Timing: Stop taking the supplement at least 7 to 14 days before any surgery to prevent bleeding complications.

Connection to Stem Cell and Regenerative Medicine

In the field of Regenerative Medicine, this herbal duo is being studied for its effect on Hematopoietic Stem Cells (HSCs). These are the “mother cells” in your bone marrow that create all your blood. Recent research (2024) suggests that Radix Astragali can protect these stem cells from premature aging caused by radiation. By keeping the stem cells “young” and functional, the supplement may help the bone marrow regenerate more effectively after a transplant or high-dose chemotherapy.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed

• Complete Blood Count (CBC): To establish baseline red and white cell levels.
• Coagulation Profile (PT/INR): To ensure your blood clots normally.
• Hormone Receptor Status: To determine if the cancer is sensitive to estrogen.

Precautions During Treatment

• Sun Safety: Wear sunscreen if you are spending time outdoors.
• Monitoring Bleeding: Watch for easy bruising or bleeding gums.

“Do’s and Don’ts” List

• Do keep your oncologist informed about every supplement you take.
• Do stay hydrated, as this helps the herbs circulate more effectively.
• Don’t take this supplement if you are currently on Warfarin or other heavy blood thinners without direct medical supervision.
• Don’t assume “natural” means it cannot interact with your chemotherapy; always cross-check with a pharmacist.

Legal Disclaimer

Standard medical information disclaimer: This guide is for informational purposes only and does not constitute medical advice. Herbal supplements are not a replacement for standard cancer treatments. Always consult with a licensed oncologist or healthcare professional before beginning any new supplement, especially during active cancer therapy. This content reflects data available as of early 2026.